Greenstone recalls methylprednisolone tablets due to incorrect dosing information on blister packaging. This may lead to improper medication doses if users follow the foil instructions.
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Take action
Contact the company
📍Recalling firmGreenstone Llc100 Route 206 North · Peapack, NJ 07977
“Greenstone Methylprednisolone Tablets Recall: Incorrect Dosing Labeling.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31553-greenstone-methylprednisolone-tablets-recall-incorrect-dosing-labeling. Based on FDA recall #D-0299-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0299-2026%22&limit=1).
Greenstone Llc recalled methylprednisolone tablets, USP Dosepak, 4 mg due to incorrect blister foil orientation that results in incorrect dosing information. The Food and Drug Administration announced the Class II recall on January 15, 2026.
The recall involves incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Context
GovInfoNow's records show Greenstone Llc has 5 other recalls on record since September 4, 2013. Other recent recalls of similar products include Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026), American Health Packaging Buprenorphine Tablets Recall (August 19, 2026), and Alvogen Thyro-Tabs 150mcg Tablets Recall (December 31, 2025).
How to tell if you have this one
Check for the NDC code 59762-4440-2 on the packaging. The product was distributed by Greenstone LLC and contains 21 tablets per blister card.
Brand
Greenstone
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Packaging
Look for the NDC code 59762-4440-2 on the packaging to identify the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 20 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0299-2026 (January 15, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0299-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.